Amrubicin
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Amrubicin, covering 2008-09-23 to 2024-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy [Phase 2]